Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells

Mol Biol Cell. 2014 Oct 1;25(19):2905-18. doi: 10.1091/mbc.E14-01-0042. Epub 2014 Aug 7.

Abstract

In cervical cancer, HPV infection and disruption of mechanisms involving cell growth, differentiation, and apoptosis are strictly linked with tumor progression and invasion. Tumor microenvironment is ATP and adenosine rich, suggesting a role for purinergic signaling in cancer cell growth and death. Here we investigate the effect of extracellular ATP on human cervical cancer cells. We find that extracellular ATP itself has a small cytotoxic effect, whereas adenosine formed from ATP degradation by ectonucleotidases is the main factor responsible for apoptosis induction. The level of P2 × 7 receptor seemed to define the main cytotoxic mechanism triggered by ATP, since ATP itself eliminated a small subpopulation of cells that express high P2 × 7 levels, probably through its activation. Corroborating these data, blockage or knockdown of P2 × 7 only slightly reduced ATP cytotoxicity. On the other hand, cell viability was almost totally recovered with dipyridamole, an adenosine transporter inhibitor. Moreover, ATP-induced apoptosis and signaling-p53 increase, AMPK activation, and PARP cleavage-as well as autophagy induction were also inhibited by dipyridamole. In addition, inhibition of adenosine conversion into AMP also blocked cell death, indicating that metabolization of intracellular adenosine originating from extracellular ATP is responsible for the main effects of the latter in human cervical cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Adenosine / metabolism*
  • Adenosine Monophosphate / biosynthesis*
  • Adenosine Triphosphate / metabolism
  • Adenosine Triphosphate / pharmacology*
  • Apoptosis / drug effects*
  • Autophagy / drug effects
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Dipyridamole / pharmacology
  • Female
  • HeLa Cells
  • Humans
  • Nucleoside Transport Proteins / antagonists & inhibitors
  • Poly(ADP-ribose) Polymerases / metabolism
  • RNA Interference
  • RNA, Messenger / biosynthesis
  • RNA, Small Interfering
  • Receptors, Purinergic P2X7 / genetics
  • Receptors, Purinergic P2X7 / metabolism
  • Tumor Microenvironment
  • Tumor Suppressor Protein p53 / biosynthesis
  • Uterine Cervical Neoplasms / drug therapy*

Substances

  • Nucleoside Transport Proteins
  • RNA, Messenger
  • RNA, Small Interfering
  • Receptors, Purinergic P2X7
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • adenosine transporter
  • Adenosine Monophosphate
  • Dipyridamole
  • Adenosine Triphosphate
  • Poly(ADP-ribose) Polymerases
  • AMP-Activated Protein Kinases
  • Adenosine